Artikel ; Online: Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth.
2023 Band 16, Heft 1, Seite(n) 158–184
Abstract: Elevated peripheral blood and tumor-infiltrating neutrophils are often associated with a poor patient prognosis. However, therapeutic strategies to target these cells are difficult to implement due to the life-threatening risk of neutropenia. In a ... ...
| Abstract | Elevated peripheral blood and tumor-infiltrating neutrophils are often associated with a poor patient prognosis. However, therapeutic strategies to target these cells are difficult to implement due to the life-threatening risk of neutropenia. In a genetically engineered mouse model of lung adenocarcinoma, tumor-associated neutrophils (TAN) demonstrate tumor-supportive capacities and have a prolonged lifespan compared to circulating neutrophils. Here, we show that tumor cell-derived GM-CSF triggers the expression of the anti-apoptotic Bcl-xL protein and enhances neutrophil survival through JAK/STAT signaling. Targeting Bcl-xL activity with a specific BH3 mimetic, A-1331852, blocked the induced neutrophil survival without impacting their normal lifespan. Specifically, oral administration with A-1331852 decreased TAN survival and abundance, and reduced tumor growth without causing neutropenia. We also show that G-CSF, a drug used to combat neutropenia in patients receiving chemotherapy, increased the proportion of young TANs and augmented the anti-tumor effect resulting from Bcl-xL blockade. Finally, our human tumor data indicate the same role for Bcl-xL on pro-tumoral neutrophil survival. These results altogether provide preclinical evidence for safe neutrophil targeting based on their aberrant intra-tumor longevity. |
|||||
|---|---|---|---|---|---|---|
| Mesh-Begriff(e) | Animals ; Humans ; Mice ; Aging ; Apoptosis ; Apoptosis Regulatory Proteins/metabolism ; bcl-X Protein ; Cell Line, Tumor ; Lung Neoplasms/pathology ; Neutropenia/drug therapy ; Neutropenia/metabolism ; Neutropenia/pathology ; Neutrophils/metabolism | |||||
| Chemische Substanzen | Apoptosis Regulatory Proteins ; bcl-X Protein ; Bcl2l1 protein, mouse | |||||
| Sprache | Englisch | |||||
| Erscheinungsdatum | 2023-12-20 | |||||
| Erscheinungsland | England | |||||
| Dokumenttyp | Journal Article | |||||
| ZDB-ID | 2467145-9 | |||||
| ISSN | 1757-4684 ; 1757-4676 | |||||
| ISSN (online) | 1757-4684 | |||||
| ISSN | 1757-4676 | |||||
| DOI | 10.1038/s44321-023-00013-x | |||||
| Signatur |
|
|||||
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 6784: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.